Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
81.5M
-
Shares change
-
+23.7M
-
Total reported value, excl. options
-
$3.91B
-
Value change
-
+$1.14B
-
Put/Call ratio
-
0.64
-
Number of buys
-
166
-
Number of sells
-
-28
-
Price
-
$47.95
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q4 2022
219 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q4 2022.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.5M shares
of 130M outstanding shares and own 62.74% of the company stock.
Largest 10 shareholders include FMR LLC (10.2M shares), VANGUARD GROUP INC (6.61M shares), JANUS HENDERSON GROUP PLC (5.97M shares), RA CAPITAL MANAGEMENT, L.P. (5.86M shares), BlackRock Inc. (5.11M shares), WELLINGTON MANAGEMENT GROUP LLP (3.53M shares), STATE STREET CORP (3.17M shares), Capital Research Global Investors (2.81M shares), Abingworth LLP (2.02M shares), and Avidity Partners Management LP (1.62M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.